Hyuk Lee1, Jeong Hwan Kim. 1. Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Abstract
AIM: To elucidate the efficacy and safety of a split dose of midazolam in combination with meperidine for colonoscopy. METHODS:Eighty subjects undergoing outpatient colonoscopy were randomly assigned to group A or B. Group A (n = 40) received a split dose of midazolam in combination with meperidine. Group B (n = 40) received a single dose of midazolam in combination with meperidine. Outcome measurements were level of sedation, duration of sedation and recovery, degree of pain and satisfaction, procedure-related memory, controllability, and adverse events. RESULTS: Group A had a lower frequency of significant hypoxemia (P = 0.043) and a higher sedation score on withdrawal of the endoscope from the descending colon than group B (P = 0.043). Group B recovered from sedation slightly sooner than group A (P < 0.002). Scores for pain and memory, except insertion-related memory, were lower in group A one week after colonoscopic examination (P = 0.018 and P < 0.030, respectively). Poor patient controllability was noted by the endoscopist and nurse in group B (P = 0.038 and P = 0.032, respectively). CONCLUSION: Split dose midazolam in combination with meperidine resulted in a safer, more equable sedation status during colonoscopic examination and a reduction in procedure-related pain and memory, but resulted in longer recovery time.
RCT Entities:
AIM: To elucidate the efficacy and safety of a split dose of midazolam in combination with meperidine for colonoscopy. METHODS: Eighty subjects undergoing outpatient colonoscopy were randomly assigned to group A or B. Group A (n = 40) received a split dose of midazolam in combination with meperidine. Group B (n = 40) received a single dose of midazolam in combination with meperidine. Outcome measurements were level of sedation, duration of sedation and recovery, degree of pain and satisfaction, procedure-related memory, controllability, and adverse events. RESULTS: Group A had a lower frequency of significant hypoxemia (P = 0.043) and a higher sedation score on withdrawal of the endoscope from the descending colon than group B (P = 0.043). Group B recovered from sedation slightly sooner than group A (P < 0.002). Scores for pain and memory, except insertion-related memory, were lower in group A one week after colonoscopic examination (P = 0.018 and P < 0.030, respectively). Poor patient controllability was noted by the endoscopist and nurse in group B (P = 0.038 and P = 0.032, respectively). CONCLUSION: Split dose midazolam in combination with meperidine resulted in a safer, more equable sedation status during colonoscopic examination and a reduction in procedure-related pain and memory, but resulted in longer recovery time.
Authors: J Patrick Waring; Todd H Baron; William K Hirota; Jay L Goldstein; Brian C Jacobson; Jonathan A Leighton; J Shawn Mallery; Douglas O Faigel Journal: Gastrointest Endosc Date: 2003-09 Impact factor: 9.427
Authors: Laura C Seeff; Thomas B Richards; Jean A Shapiro; Marion R Nadel; Diane L Manninen; Leslie S Given; Fred B Dong; Linda D Winges; Matthew T McKenna Journal: Gastroenterology Date: 2004-12 Impact factor: 22.682
Authors: Sandeep Patel; John J Vargo; Farah Khandwala; Rocio Lopez; Pat Trolli; John A Dumot; Darwin L Conwell; Gregory Zuccaro Journal: Am J Gastroenterol Date: 2005-12 Impact factor: 10.864
Authors: Michał Jan Stasiowski; Małgorzata Starzewska; Ewa Niewiadomska; Seweryn Król; Kaja Marczak; Jakub Żak; Aleksandra Pluta; Jerzy Eszyk; Beniamin Oskar Grabarek; Izabela Szumera; Michał Nycz; Anna Missir; Lech Krawczyk; Przemysław Jałowiecki Journal: Pharmaceuticals (Basel) Date: 2021-05-14